Newer HMG-CoA reductase inhibitor (statin) therapies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jacobson, 2000, Impact of evidence-based “clinical judgment” on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data, Arch Intern Med, 160, 1361, 10.1001/archinte.160.9.1361
Lipitor (atorvastatin calcium) tablets (package insert). Morris Plains, N.J.: Parke-Davis, 2000
Pravachol (pravastatin sodium) tablets (package insert). Princeton, N.J.: Bristol-Myers Squibb Co., 2000
Zocor (simvastatin) tablets (package insert). West Point, Pa.: Merck & Co., Inc., 2000
Schwartz, 2001, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: A randomized controlled trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711
Wagner, 2000, Improvement of nitric oxide-dependent vasodilation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation, Arterioscler Thromb Vase Biol, 20, 61, 10.1161/01.ATV.20.1.61
Aikawa, 2001, An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro, Circulation, 103, 276, 10.1161/01.CIR.103.2.276
Ridker, 1999, Long-term effects of pravastatin on plasma concentration of C-reactive protein, Circulation, 100, 230, 10.1161/01.CIR.100.3.230
Romano, 2000, Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: Role of nitric oxide, J Investig Med, 48, 183
Bellosta, 2000, Pleiotropic effects of statins in atherosclerosis and diabetes, Diabetes Care, 23, B72
Baycol (cerivastatin sodium) tablets (package insert). West Haven, Conn.: Bayer Corp., 2000
Stein, 1999, Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia, Am J Cardiol, 83, 1433, 10.1016/S0002-9149(99)00120-4
Lesco (fluvastatin sodium) capsules (package insert). East Hanover, N.J.: Novartis Pharmaceuticals Corp., 1999